Bozena Smolkova Department of Molecular Oncology, Cancer Research Institute Biomedical Research Center of the Slovak Academy of Sciences Biography Publications Institution JoVE Articles Bozena Smolkova has not added a biography. If you are Bozena Smolkova and would like to personalize this page please email our Author Liaison for assistance. Publications Genotoxic Effects of Occupational Exposure to Glass Fibres - A Human Biomonitoring Study Mutation Research. Genetic Toxicology and Environmental Mutagenesis. Jan, 2023 | Pubmed ID: 36669817 The Metastatic Process Through the Eyes of Epigenetic Regulation: A Promising Horizon for Cancer Therapy International Journal of Molecular Sciences. Dec, 2022 | Pubmed ID: 36555088 Liquid Biopsy and Preclinical Tools for Advancing Diagnosis and Treatment of Patients with Pancreatic Neuroendocrine Neoplasms Critical Reviews in Oncology/hematology. Dec, 2022 | Pubmed ID: 36334880 Decitabine-induced DNA Methylation-mediated Transcriptomic Reprogramming in Human Breast Cancer Cell Lines; the Impact of DCK Overexpression Frontiers in Pharmacology. 2022 | Pubmed ID: 36278182 A Pooled Analysis of Molecular Epidemiological Studies on Modulation of DNA Repair by Host Factors Mutation Research. Genetic Toxicology and Environmental Mutagenesis. 2022 | Pubmed ID: 35483778 Decitabine Potentiates Efficacy of Doxorubicin in a Preclinical Trastuzumab-resistant HER2-positive Breast Cancer Models Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. Mar, 2022 | Pubmed ID: 35091237 MiR-205-5p Downregulation and Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer International Journal of Molecular Sciences. Dec, 2021 | Pubmed ID: 35008529 Chemotherapy-triggered Changes in Stromal Compartment Drive Tumor Invasiveness and Progression of Breast Cancer Journal of Experimental & Clinical Cancer Research : CR. Sep, 2021 | Pubmed ID: 34579743 Author Correction: DNA Damage in Circulating Leukocytes Measured with the Comet Assay May Predict the Risk of Death Scientific Reports. Sep, 2021 | Pubmed ID: 34545156 DNA Damage in Circulating Leukocytes Measured with the Comet Assay May Predict the Risk of Death Scientific Reports. Aug, 2021 | Pubmed ID: 34408182 DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations Frontiers in Genetics. 2021 | Pubmed ID: 34220964 The HCOMET Project: International Database Comparison of Results with the Comet Assay in Human Biomonitoring. Baseline Frequency of DNA Damage and Effect of Main Confounders Mutation Research. Reviews in Mutation Research. 2021 | Pubmed ID: 34083035 Targeting the Gut Microbiome: An Emerging Trend in Hematopoietic Stem Cell Transplantation Blood Reviews. Jul, 2021 | Pubmed ID: 33573867 Decreased Levels of Circulating Cytokines VEGF, TNF-β and IL-15 Indicate PD-L1 Overexpression in Tumours of Primary Breast Cancer Patients Scientific Reports. Jan, 2021 | Pubmed ID: 33446741 Intracellular Prodrug Gene Therapy for Cancer Mediated by Tumor Cell Suicide Gene Exosomes International Journal of Cancer. Jan, 2021 | Pubmed ID: 32621791 Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients International Journal of Molecular Sciences. Dec, 2020 | Pubmed ID: 33322711 Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives Cancers. Dec, 2020 | Pubmed ID: 33287297 Validating FPSA Glycoprofile As a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies Cancers. Oct, 2020 | Pubmed ID: 33076457 Targeting Epigenetic Modifications in Uveal Melanoma International Journal of Molecular Sciences. Jul, 2020 | Pubmed ID: 32726977 Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance? International Journal of Molecular Sciences. Jun, 2020 | Pubmed ID: 32521716 Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Cancers. May, 2020 | Pubmed ID: 32369910 Immunotoxicity, Genotoxicity and Epigenetic Toxicity of Nanomaterials: New Strategies for Toxicity Testing? Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. Nov, 2017 | Pubmed ID: 28847762 Nanomedicine and Epigenome. Possible Health Risks Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. Nov, 2017 | Pubmed ID: 28705729 Expression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral Blood Translational Oncology. Jun, 2016 | Pubmed ID: 27267835 Genetic Determinants of Quantitative Traits Associated with Cardiovascular Disease Risk Mutation Research. Aug, 2015 | Pubmed ID: 26043189 NBN and XRCC3 Genetic Variants in Childhood Acute Lymphoblastic Leukaemia Cancer Epidemiology. Oct, 2014 | Pubmed ID: 25176580 Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 Cancer Research
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 Cancer Research